CPRT Form 4: Director exercises options at $4.91, sells at $47.54
Rhea-AI Filing Summary
Copart Inc. (CPRT) director Thomas N. Tryforos reported exercising stock options and simultaneously selling the underlying shares on 09/15/2025. The Form 4 shows Tryforos acquired 228,840 shares by exercising options at an exercise price of $4.91 per share and sold 228,840 shares at a weighted average price of $47.54 per share (sales ranged from $47.38 to $47.70). Following these transactions the reporting person beneficially owned 0 shares. The filing was signed by an attorney-in-fact on 09/17/2025 and references the company’s 2007 Equity Incentive Plan and prior option adjustments due to stock splits.
Positive
- Full disclosure of exercise and sale details, including weighted average sale price and price range
- Compliance with Section 16 reporting requirements; form is signed and includes explanatory notes about option adjustments
Negative
- Reporting person beneficially owns 0 shares after the transactions, eliminating direct insider equity stake disclosed here
- Large disposition of 228,840 shares may reduce any perceived insider-aligned ownership from this director
Insights
TL;DR: Director exercised options and sold the entire resulting position, realizing a substantial spread between exercise and sale prices.
The filing documents a routine option exercise followed by an immediate disposition of 228,840 shares, producing a large per-share gain given the $4.91 exercise price versus a ~$47.54 weighted sale price. This is a straightforward liquidity event rather than an operational signal from the company; the immediate sale resulted in zero beneficial ownership, so no continuing insider holding remains to signal confidence.
TL;DR: Form 4 shows compliant, timely disclosure of an option exercise and sale that leaves the director with no direct holdings.
The report appears complete and includes a range of sale prices and explanatory notes about option adjustments for past stock splits and vesting schedule. From a governance perspective, disclosure was made and the transaction was signed by an attorney-in-fact, indicating procedural compliance. The filing does not provide any additional commentary or insider intent.